{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:45:21Z","timestamp":1789040721882,"version":"build-2803163510"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Invasive candidiasis (IC) is a serious infection among children with underlying medical conditions. A shift from\n                      <jats:italic toggle=\"yes\">C. albicans<\/jats:italic>\n                      to non-\n                      <jats:italic toggle=\"yes\">albicans Candida<\/jats:italic>\n                      has been observed worldwide. This study aims to identify species of\n                      <jats:italic toggle=\"yes\">Candida<\/jats:italic>\n                      and factors associated with the overall 30-day mortality rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective chart review was conducted among children with culture-confirmed IC from birth to 15 years of age at King Chulalongkorn Memorial Hospital, Thailand. Multivariate Cox regression analysis was performed to determine associated factors with 30-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      From 2003 to 2019, 102 episodes of IC in pediatric group with a median age of 16 months (interquartile range 4\u201365) and 12 episodes of IC in neonatal group with a median age of 18 days (interquartile range 12\u201322). The species distribution were\n                      <jats:italic toggle=\"yes\">Candida albicans<\/jats:italic>\n                      (35%),\n                      <jats:italic toggle=\"yes\">Candida parapsilosis<\/jats:italic>\n                      (26%),\n                      <jats:italic toggle=\"yes\">Candida tropicalis<\/jats:italic>\n                      (22%),\n                      <jats:italic toggle=\"yes\">Candida glabrata<\/jats:italic>\n                      (6%) and other\/unspecified species (11%). Antifungal treatment was given in 88% (67% Amphotericin B deoxycholate, 28% Fluconazole). Overall 30-day mortality rates were 28.5% [95% confidence interval (CI) 20.8%\u201338.4%] and 8.3% (95% CI 1.2%\u201346.1%) in pediatrics and neonates, respectively. Mortality rate among the neutropenic group was significantly higher than non-neutropenic group (46.4% vs. 20.6%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.005). Factors associated with 30-day mortality in pediatric IC were shock [adjusted hazard ratio (aHR) 4.2; 95% CI 1.8\u20139.4], thrombocytopenia (aHR 7.7; 95% CI 1.8\u201333.9) and no antifungal treatment (aHR 4.6; 95% CI 1.7\u201312.1).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Two-third of children with IC were diagnosed with non-\n                      <jats:italic toggle=\"yes\">albicans Candida.<\/jats:italic>\n                      Children with high mortality rate included those with neutropenia, presented with shock or thrombocytopenia, such that the proper empiric antifungal treatment is recommended.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000002912","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T02:05:20Z","timestamp":1601949920000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Pediatric and Neonatal Invasive Candidiasis"],"prefix":"10.1097","volume":"40","author":[{"given":"Watsamon","family":"Jantarabenjakul","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatnapa","family":"Yodkitudomying","sequence":"additional","affiliation":[{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariya","family":"Chindamporn","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintip","family":"Suchartlikitwong","sequence":"additional","affiliation":[{"name":"Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand"},{"name":"Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvaporn","family":"Anugulruengkitt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitsanu","family":"Pancharoen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Center of Excellence in Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"e15933","DOI":"10.1097\/MD.0000000000015933","article-title":"Invasive candidiasis: risk factor for mortality in a pediatric tertiary care hospital in south of Brazil.","volume":"98","author":"Rodrigues","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.idc.2015.10.013","article-title":"Invasive candidiasis.","volume":"30","author":"McCarty","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/655698","article-title":"Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.","volume":"51","author":"Zaoutis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jof5010019","article-title":"Changing epidemiology of invasive candidiasis in children during a 10-year period.","volume":"5","author":"Noni","year":"2019","journal-title":"J Fungi"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0039-1695061","article-title":"Invasive Candida infections in a pediatric intensive care unit in Turkey: evaluation of an 11-year period.","volume":"9","author":"Aslan","year":"2020","journal-title":"J Pediatr Intensive Care"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jof2010005","article-title":"Pediatric invasive candidiasis: epidemiology and diagnosis in children.","volume":"2","author":"Steinbach","year":"2016","journal-title":"J Fungi (Basel)"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/mmy\/myz005","article-title":"Health care-associated invasive Candida infections in children.","volume":"57","author":"\u00d6nc\u00fc","year":"2019","journal-title":"Med Mycol"},{"issue":"suppl_1","key":"R9-20250615","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children.","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","article-title":"Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study.","volume":"21","author":"Tan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period.","volume":"40","author":"Colombo","year":"2014","journal-title":"Intensive Care Med"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"684.e1","DOI":"10.1016\/j.cmi.2015.02.029","article-title":"A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.","volume":"21","author":"Cuervo","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America.","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-2003-40008","article-title":"Neonatal invasive candidiasis: a prospective multicenter study of 118 cases.","volume":"20","author":"Sastre","year":"2003","journal-title":"Am J Perinatol"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1542\/peds.2009-3412","article-title":"Neonatal candidiasis: epidemiology, risk factors, and clinical judgment.","volume":"126","author":"Benjamin","year":"2010","journal-title":"Pediatrics"},{"key":"R16-20250615","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13146","article-title":"Epidemiology, antifungal susceptibility, risk factors and mortality of invasive candidiasis in neonates and children in a tertiary teaching hospital in Southwest China.","author":"Zeng","year":"2020","journal-title":"Mycoses"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/myc.12698","article-title":"Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children\u2019s Medical Center, Tehran.","volume":"61","author":"Charsizadeh","year":"2018","journal-title":"Mycoses"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10096-002-0822-1","article-title":"Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death.","volume":"21","author":"Viudes","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12879-018-3100-2","article-title":"Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.","volume":"18","author":"Hsu","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/INF.0000000000000039","article-title":"Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome.","volume":"33","author":"Santolaya","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2147\/IDR.S196972","article-title":"Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility.","volume":"12","author":"Khairat","year":"2019","journal-title":"Infect Drug Resist"},{"key":"R23-20250615","first-page":"59","article-title":"Epidemiology of Candidemia at King Chulalongkorn Memorial Hospital, Thailand.","volume":"22","author":"Tritipwanit","year":"2005","journal-title":"J Infect Dis Antimicrob Agents"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1016\/j.ijid.2011.06.006","article-title":"Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK.","volume":"15","author":"Das","year":"2011","journal-title":"Int J Infect Dis"},{"key":"R26-20250615","first-page":"927","article-title":"Epidemiology of candidemia in Songklanagarind Hospital.","volume":"94","author":"Jutiamornlerd","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2217\/fmb-2016-0099","article-title":"Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.","volume":"11","author":"Wang","year":"2016","journal-title":"Future Microbiol"},{"issue":"suppl 6","key":"R28-20250615","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia.","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R29-20250615","first-page":"108","article-title":"Prevalence of Candida bloodstream isolates from patients in two hospitals in Vietnam.","volume":"11","author":"Bac","year":"2019","journal-title":"Iran J Microbiol"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0b013e318213da0f","article-title":"Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population.","volume":"30","author":"Dutta","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20250615","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/myc.12288","article-title":"Candidaemia in a paediatric centre and importance of central venous catheter removal.","volume":"58","author":"Karadag-Oncel","year":"2015","journal-title":"Mycoses"},{"key":"R33-20250615","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/INF.0b013e31824da7fe","article-title":"Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children.","volume":"31","author":"Dotis","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/myc.12792","article-title":"Candidemia in children: epidemiology, prevention and management.","volume":"61","author":"Mantadakis","year":"2018","journal-title":"Mycoses"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1128\/JCM.42.10.4468-4472.2004","article-title":"Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital.","volume":"42","author":"Clark","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.70.2.878-888.2002","article-title":"Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces.","volume":"70","author":"Kuhn","year":"2002","journal-title":"Infect Immun"},{"key":"R37-20250615","first-page":"322","article-title":"Antifungal susceptibility analysis of clinical isolates of Candida parapsilosis in Iran.","volume":"45","author":"Lotfali","year":"2016","journal-title":"Iran J Public Health"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1128\/AAC.01177-15","article-title":"Candida parapsilosis resistance to fluconazole: molecular mechanisms and in vivo impact in infected Galleria mellonella Larvae.","volume":"59","author":"Souza","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R39-20250615","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JCM.01398-10","article-title":"Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009).","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R40-20250615","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis.","volume":"58","author":"Fern\u00e1ndez-Ruiz","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R41-20250615","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ajic.2016.03.056","article-title":"Epidemiologic and microbiologic evaluation of nosocomial infections associated with Candida spp in children: a multicenter study from Istanbul, Turkey.","volume":"44","author":"Sutcu","year":"2016","journal-title":"Am J Infect Control"},{"key":"R42-20250615","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0000000000002207","article-title":"Pediatric Candidemia epidemiology and morbidities: a nationwide cohort.","volume":"38","author":"Lausch","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl 1","key":"R43-20250615","first-page":"22","article-title":"Invasive candidiasis in the neutropenic patient.","volume":"30","author":"Fort\u00fan","year":"2017","journal-title":"Rev Esp Quimioter"},{"key":"R44-20250615","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10096-008-0546-y","article-title":"A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia.","volume":"27","author":"Velasco","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R45-20250615","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R46-20250615","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.inf.0000172938.76561.8e","article-title":"Risk factors for mortality in children with candidemia.","volume":"24","author":"Zaoutis","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R47-20250615","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jmii.2010.08.010","article-title":"Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.","volume":"44","author":"Chi","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"R48-20250615","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00134-015-3866-2","article-title":"A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality.","volume":"41","author":"Bassetti","year":"2015","journal-title":"Intensive Care Med"},{"key":"R49-20250615","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1186\/s12879-019-4588-9","article-title":"Surveillance study of the prevalence, species distribution, antifungal susceptibility, risk factors and mortality of invasive candidiasis in a tertiary teaching hospital in Southwest China.","volume":"19","author":"Zeng","year":"2019","journal-title":"BMC Infect Dis"},{"key":"R50-20250615","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/21548331.2018.1518104","article-title":"Management of patients with septic shock due to Candida infection.","volume":"46","author":"Bassetti","year":"2018","journal-title":"Hosp Pract (1995)"},{"key":"R51-20250615","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/jof5010011","article-title":"Invasive candidiasis in infants and children: recent advances in epidemiology, diagnosis, and treatment.","volume":"5","author":"Walsh","year":"2019","journal-title":"J Fungi"},{"key":"R52-20250615","first-page":"200","article-title":"Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.","volume":"38","author":"Chen","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"R53-20250615","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1542\/peds.106.4.712","article-title":"When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.","volume":"106","author":"Benjamin","year":"2000","journal-title":"Pediatrics"},{"issue":"suppl 7","key":"R54-20250615","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R55-20250615","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.jp.7211628","article-title":"Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures.","volume":"27","author":"Cohen-Wolkowiez","year":"2007","journal-title":"J Perinatol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T12:05:57Z","timestamp":1749989157000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002912"}},"subtitle":["Species Distribution and Mortality Rate in a Thai Tertiary Care Hospital"],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002912","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}